Filing Flows › Xtant Medical Holdings (XTNT) › Q1 2025
Xtant Medical Holdings (XTNT) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 12, 2025
Xtant Medical Holdings (XTNT) reported revenue of $32.9M for the first quarter 2025 (Q1 2025), +18% from a year earlier and +4% from the quarter before. Operating margin was 3.2%, net earnings $58K (0.2% of revenue).
Xtant Medical Holdings, Q1 2025: revenue $32.9M (+18% year over year), operating margin 3.2%, net earnings $58K, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.9M | +4% | +18% |
| Gross profit | $20.2M | +26% | +17% |
| Operating profit | $1.1M | — | — |
| Net earnings | $58K | — | — |
| Operating cash flow | $1.3M | +92% | — |
| Free cash flow | $87K | — | — |
What changed
Revenue was $32.9M in Q1 2025, up 18% year over year and up 4% from the previous quarter. Orthobiologics was the largest line at 55% of revenue. Orthobiologics added $2.7M year over year (up 17%), 53% of the total change. Spinal Implant declined 10%.
Gross margin was 61.5%, down 0.6 points from a year earlier. Operating profit was $1.1M, a 3.2% margin (up 15.7 points year over year). Operating expenses fell 8% while revenue rose 18%. Net earnings were $58K. The effective tax rate was -75.8%.
Operating cash flow was $1.3M, 2203% of net earnings. Non-cash charges added back $1.1M of depreciation and amortization and $758K of share-based compensation. Working capital and other items used $612K. Capital expenditures of $1.2M left free cash flow of $87K.
Questions
What was Xtant Medical Holdings' revenue in the first quarter 2025?
Xtant Medical Holdings (XTNT) reported revenue of $32.9M for the first quarter 2025 (Q1 2025), +18% from a year earlier and +4% from the quarter before.
Was Xtant Medical Holdings profitable in the first quarter 2025?
Operating profit was $1.1M (3.2% of revenue) and net earnings $58K.